STOCK TITAN
  1. Home
  2. Sec-filings
  3. SONN
  4. [EFFECT] Sonnet BioTherapeutics Holdings, Inc. SEC Filing

[EFFECT] Sonnet BioTherapeutics Holdings, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
EFFECT
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: December 16, 2025
Accession Number: 0001493152-25-026938
Submission Type: POS AM
CIK: 0001106838
Company Name: Sonnet BioTherapeutics Holdings, Inc.
File Number: 333-258092

Source: View Original Filing on SEC EDGAR

Stock SONN logo
Sonnet Biotherapeutc Hldng Inc

NASDAQ:SONN

SONN Rankings

#6374 Ranked by Market Cap
N/A Ranked by Dividends

SONN Latest News

Dec 2, 2025
Hyperliquid Strategies Inc and Sonnet BioTherapeutics Holdings, Inc. Announce Closing of Business Combination
Dec 2, 2025
Sonnet BioTherapeutics Holdings, Inc. Announces Stockholder Approval of Proposed Business Combination with Hyperliquid Strategies Inc
Nov 18, 2025
Sonnet BioTherapeutics Holdings, Inc. Announces Adjournment of Special Meeting
Sep 19, 2025
Sonnet to Present at the MedInvest Biotech & Pharma Conference
Aug 11, 2025
Sonnet Releases Virtual Investor "What This Means" Segment

SONN Latest SEC Filings

Dec 3, 2025
[Form 4] Sonnet BioTherapeutics Holdings, Inc. Insider Trading Activity
Dec 17, 2025
[EFFECT] Sonnet BioTherapeutics Holdings, Inc. SEC Filing
Dec 17, 2025
[EFFECT] Sonnet BioTherapeutics Holdings, Inc. SEC Filing
Dec 17, 2025
[EFFECT] Sonnet BioTherapeutics Holdings, Inc. SEC Filing
Dec 17, 2025
[EFFECT] Sonnet BioTherapeutics Holdings, Inc. SEC Filing

SONN Stock Data

8.60M
6.80M
4.4%
5.56%
27.33%
Biotechnology
Pharmaceutical Preparations
Link
United States
PRINCETON